About ixekiz umab
Interleukin-17A inhibitor
Used for
- Plaque psoriasis
- Psoriatic arthritis
- Axial spondyloarthritis, including ankylosing spondylitis
Usual adult dose
Usually 160 mg initially, then 80 mg every 2 or 4 weeks, depending on condition.
Usual dose in children
For plaque psoriasis from age 6: weight-based starting dose, then weight-based doses every 4 weeks.
Common side effects
- Injection-site reactions
- Upper respiratory infections
- Nausea
- Fungal infections
Important warnings
- Serious infections may occur; treatment is avoided during active serious infection.
- Screen for tuberculosis before starting treatment.
- May worsen inflammatory bowel disease or trigger new symptoms.
- Live vaccines should be avoided during treatment.
Pregnancy
Human pregnancy data are limited; use only when potential benefit justifies possible risk.
Breastfeeding
It is unknown whether ixekizumab passes into breast milk; clinical advice is needed.
Interactions
- Live vaccines may be less safe or effective.
- Other biologic immune-suppressing medicines may increase infection risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.